In contrast, previous analysis in plasma (12,39,47), erythrocytes, and whole blood (41,43,48) of women with breast cancer showed decreased SOD, CAT, and GPx activity, being therefore insufficient for antioxidant protection (43,49). The gene discussed is CAT; the disease is breast carcinoma.